Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2019	FY 2017	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Jan 1, 2017
Chemical Products	978.83M	851.29M	862.47M	1.00B	741.35M
Chemical Products Growth	14.98%	-1.30%	-14.13%	35.49%	16.89%
Others	66.61M	58.67M	56.98M	53.68M	41.86M
Others Growth	13.54%	2.96%	6.15%	28.24%	-5.10%
Total	1.05B	909.96M	919.45M	1.06B	783.21M
Total Growth	14.89%	-1.03%	-13.10%	35.10%	15.46%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2019	FY 2017	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Jan 1, 2017
China	835.77M	723.99M	754.18M	866.54M	622.84M
China Growth	15.44%	-4.00%	-12.97%	39.13%	18.51%
Overseas	209.67M	185.96M	165.27M	191.56M	160.37M
Overseas Growth	12.75%	12.52%	-13.73%	19.45%	4.98%
Total	1.05B	909.96M	919.45M	1.06B	783.21M
Total Growth	14.89%	-1.03%	-13.10%	35.10%	15.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error